Pancreatic Enzyme Supplementation for Celiac Disease
Status:
Terminated
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this protocol is to conduct a pilot study to investigate whether pancreatic
enzyme supplementation will improve symptoms in individuals with celiac disease who suffer
persistent symptoms despite a gluten free diet. This protocol specifically aims to:
1. Evaluate the efficacy of pancreatic enzyme supplementation for reduction of
gastrointestinal symptoms in patients with celiac disease on a gluten free diet.
2. Assess the ability of fecal elastase levels to predict response to pancreatic enzyme
supplementation in patients with celiac disease on a gluten free diet.